Globus Enterprise Value Over E B I T D A from 2010 to 2024

GMED Stock  USD 50.75  0.45  0.88%   
Globus Medical's Enterprise Value Over EBITDA is increasing over the years with slightly volatile fluctuation. Enterprise Value Over EBITDA is expected to dwindle to 13.00. During the period from 2010 to 2024 Globus Medical Enterprise Value Over EBITDA annual values regression line had geometric mean of  14.31 and mean square error of  38.11. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
15.15968359
Current Value
13
Quarterly Volatility
7.81545845
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus main balance sheet or income statement drivers, such as Depreciation And Amortization of 152 M, Interest Expense of 21.1 M or Total Revenue of 1.6 B, as well as many exotic indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 1.43. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
  
This module can also supplement Globus Medical's financial leverage analysis and stock options assessment as well as various Globus Medical Technical models . Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Latest Globus Medical's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Globus Medical over the last few years. It is Globus Medical's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Globus Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Globus Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean16.04
Geometric Mean14.31
Coefficient Of Variation48.74
Mean Deviation6.17
Median14.87
Standard Deviation7.82
Sample Variance61.08
Range28.3734
R-Value0.65
Mean Square Error38.11
R-Squared0.42
Significance0.01
Slope1.13
Total Sum of Squares855.14

Globus Enterprise Value Over E B I T D A History

2024 13.0
2023 15.16
2022 23.32
2021 24.51
2020 33.91
2019 24.55
2018 18.12

About Globus Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Globus Medical income statement, its balance sheet, and the statement of cash flows. Globus Medical investors use historical funamental indicators, such as Globus Medical's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may use each financial statement separately, they are all related. The changes in Globus Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Globus Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Globus Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 15.16  13.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.